Latest results FY2026 · Prices updated Oct 30, 2026
HQ: Tokyo, TokyoFounded 200367 employeesWebsite
A major healthcare group centered on pharmaceutical wholesaling. It supports the stable supply of prescription medicines and medical devices through a nationwide logistics network.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Prescription Drug Wholesale Business | 89% | ¥2.8T | ¥33.3B | 1.2% |
| Self-Medication Wholesale Business | 9% | ¥267.1B | ¥3.0B | 1.1% |
| Pharmaceuticals and Related Manufacturing | 2% | ¥52.2B | ¥1.2B | 2.3% |
| Pharmacies and Related Businesses | 1% | ¥37.2B | ¥499M | 1.3% |
| Other Businesses | 0% | ¥0 | ¥-1.1B | — |
Close (Oct 30, 2026)
¥2,469+16.4% (1Y)
Alfresa +16.4% over 1Y, 10.5pt below the industry average (34 companies, +26.9%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥3.1T | ¥36.2B | ¥41.7B | ¥1.5T | — |
Sources: annual securities reports, earnings releases and other public disclosures (Dec 2025)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
